| Gastroenteropancreatic neuroendocrine tumours IM Modlin, K Oberg, DC Chung, RT Jensen, WW De Herder, RV Thakker, ... The lancet oncology 9 (1), 61-72, 2008 | 2035 | 2008 |
| Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival DJ Kwekkeboom, WW de Herder, BL Kam, CH van Eijck, M van Essen, ... Journal of Clinical Oncology 26 (13), 2124-2130, 2008 | 1687 | 2008 |
| TNM staging of foregut (neuro) endocrine tumors: a consensus proposal including a grading system G Rindi, G Klöppel, XXH Alhman, M Caplin, A Couvelard, WW De Herder, ... Virchows Archiv 449, 395-401, 2006 | 1665 | 2006 |
| Octreotide SWJ Lamberts, AJ Van der Lely, WW de Herder, LJ Hofland new england Journal of Medicine 334 (4), 246-254, 1996 | 1457 | 1996 |
| Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors DJ Kwekkeboom, JJ Teunissen, WH Bakker, PP Kooij, WW de Herder, ... Journal of Clinical Oncology 23 (12), 2754-2762, 2005 | 818 | 2005 |
| Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system K Öberg, L Kvols, M Caplin, G Delle Fave, W de Herder, G Rindi, ... Annals of Oncology 15 (6), 966-973, 2004 | 734 | 2004 |
| NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas MH Kulke, LB Anthony, DL Bushnell, WW De Herder, SJ Goldsmith, ... Pancreas 39 (6), 735-752, 2010 | 688 | 2010 |
| ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes RT Jensen, G Cadiot, ML Brandi, WW De Herder, G Kaltsas, P Komminoth, ... Neuroendocrinology 95 (2), 98-119, 2012 | 651 | 2012 |
| Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours U Plöckinger, G Rindi, R Arnold, B Eriksson, EP Krenning, WW De Herder, ... Neuroendocrinology 80 (6), 394-424, 2004 | 627 | 2004 |
| Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors DJ Kwekkeboom, BL Kam, M Van Essen, JJM Teunissen, CHJ van Eijck, ... Endocrine-related cancer 17 (1), R53, 2010 | 545 | 2010 |
| An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective … FH van Nederveen, J Gaal, J Favier, E Korpershoek, RA Oldenburg, ... The lancet oncology 10 (8), 764-771, 2009 | 544 | 2009 |
| TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study G Rindi, M Falconi, C Klersy, L Albarello, L Boninsegna, MW Buchler, ... Journal of the National Cancer Institute 104 (10), 764-777, 2012 | 538 | 2012 |
| Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the α-subunit of glycoprotein hormones FRE Nobels, DJ Kwekkeboom, W Coopmans, CHH Schoenmakers, ... The Journal of Clinical Endocrinology & Metabolism 82 (8), 2622-2628, 1997 | 538 | 1997 |
| Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0] octreotide: the Rotterdam experience R Valkema, M De Jong, WH Bakker, WAP Breeman, PPM Kooij, ... Seminars in nuclear medicine 32 (2), 110-122, 2002 | 535 | 2002 |
| Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate DJ Kwekkeboom, WH Bakker, BL Kam, JJM Teunissen, PPM Kooij, ... European journal of nuclear medicine and molecular imaging 30, 417-422, 2003 | 515 | 2003 |
| Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors T Brabander, WA van der Zwan, JJM Teunissen, BLR Kam, RA Feelders, ... Clinical Cancer Research 23 (16), 4617-4624, 2017 | 503 | 2017 |
| ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms G Delle Fave, D O''Toole, A Sundin, B Taal, P Ferolla, JK Ramage, ... Neuroendocrinology 103 (2), 119-124, 2016 | 500 | 2016 |
| MDText. com KR Feingold, B Anawalt, A Boyce, G Chrousos, WW De Herder, ... Inc.: South Dartmouth, MA, USA, 2000 | 448 | 2000 |
| [123I]Metaiodobenzylguanidine and[ 111In]Octreotide Uptake in Benign and Malignant Pheochromocytomas E Van der Harst, WW de Herder, HA Bruining, HJ Bonjer, RR de Krijger, ... The Journal of Clinical Endocrinology & Metabolism 86 (2), 685-693, 2001 | 402 | 2001 |
| Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas: An International Collaborative Study AF Daly, MA Tichomirowa, P Petrossians, E Heliovaara, ML Jaffrain-Rea, ... The Journal of Clinical Endocrinology & Metabolism 95 (11), E373-E383, 2010 | 395 | 2010 |
